EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.3.1.39 | Adenocarcinoma of Lung |
32438613 |
Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 2.3.1.39 | Adenoma |
10632348 |
Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
2
1 |
| 2.3.1.39 | Adenoma |
11903600 |
Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
3
1 |
| 2.3.1.39 | Adenoma |
12170454 |
P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids. |
diagnostic usage
therapeutic application
unassigned |
2
1
0 |
| 2.3.1.39 | Adenoma |
19358283 |
Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention. |
causal interaction
diagnostic usage
unassigned |
3
3
0 |
| 2.3.1.39 | Adenoma |
30597641 |
Fatty acid synthase and Ki-67 immunoexpression can be useful for the identification of malignant component in carcinoma ex-pleomorphic adenoma. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 2.3.1.39 | Adenoma, Pleomorphic |
20701095 |
Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 2.3.1.39 | Adenoma, Pleomorphic |
21385214 |
Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
1 |
| 2.3.1.39 | Alzheimer Disease |
32863221 |
CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease. |
ongoing research
unassigned |
2
0 |
| 2.3.1.39 | Ameloblastoma |
30692057 |
Comparison of fatty acid synthase and cyclooxygenase-2 immunoexpression in embryonal, benign, and malignant odontogenic tissues. |
diagnostic usage
ongoing research
unassigned |
1
2
0 |
